Go Pro

Atomera (NASDAQ:ATOM) Downgraded by Wall Street Zen to "Sell"

Atomera logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen downgraded Atomera from “Hold” to “Sell,” while Weiss Ratings reaffirmed its “Sell (e+)” rating. MarketBeat reports the stock’s average analyst rating is now “Sell.”
  • Atomera reported a quarterly loss of $0.17 per share, missing the $0.13-loss consensus estimate, although revenue of $0.16 million exceeded expectations of $0.10 million.
  • Shares opened at $5.60, compared with a 52-week range of $1.89 to $12.36; the company has a market capitalization of approximately $218.5 million and remains deeply unprofitable, with a negative net margin of 9,742.17%.
  • Five stocks to consider instead of Atomera.

Atomera (NASDAQ:ATOM - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a note issued to investors on Monday.

Separately, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Atomera in a research report on Wednesday. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Atomera currently has an average rating of "Sell".

Get Our Latest Research Report on ATOM

Atomera Price Performance

ATOM opened at $5.60 on Monday. Atomera has a fifty-two week low of $1.89 and a fifty-two week high of $12.36. The company's 50 day moving average price is $6.71 and its two-hundred day moving average price is $6.18. The firm has a market capitalization of $218.51 million, a price-to-earnings ratio of -8.62 and a beta of 2.11.

Atomera (NASDAQ:ATOM - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The technology company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by ($0.04). The business had revenue of $0.16 million for the quarter, compared to the consensus estimate of $0.10 million. Atomera had a negative net margin of 9,742.17% and a negative return on equity of 77.91%.

Insider Activity at Atomera

In other news, CFO Francis Laurencio sold 20,400 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $9.44, for a total transaction of $192,576.00. Following the completion of the sale, the chief financial officer directly owned 253,353 shares in the company, valued at $2,391,652.32. This represents a 7.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 8.10% of the company's stock.

Hedge Funds Weigh In On Atomera

Several hedge funds and other institutional investors have recently bought and sold shares of the company. HRT Financial LP acquired a new stake in Atomera during the 4th quarter worth about $29,000. Legal & General Group Plc acquired a new position in shares of Atomera in the 2nd quarter valued at about $32,000. AQR Capital Management LLC lifted its stake in shares of Atomera by 25.2% in the 4th quarter. AQR Capital Management LLC now owns 22,210 shares of the technology company's stock valued at $49,000 after purchasing an additional 4,475 shares during the period. Abel Hall LLC bought a new stake in shares of Atomera during the 1st quarter valued at about $53,000. Finally, The Manufacturers Life Insurance Company bought a new stake in shares of Atomera during the 2nd quarter valued at about $53,000. Institutional investors and hedge funds own 30.79% of the company's stock.

Atomera Company Profile

(Get Free Report)

Atomera Inc is a materials engineering company that develops and licenses advanced thin film technologies for the semiconductor industry. Its flagship offering, Mears Silicon Technology (MST), is designed to enhance transistor performance, improve power efficiency and boost device yields. Atomera's solutions are integrated into existing fabrication processes without major changes to equipment or materials flows, enabling foundries and integrated device manufacturers to adopt the technology with minimal disruption.

At the core of Atomera's business model is the licensing and patent-licensing of MST.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Atomera Right Now?

Before you consider Atomera, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Atomera wasn't on the list.

While Atomera currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines